RecruitingNCT07239583

Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )

A Description of the Proportion, Genotype Distribution of Respiratory Syncytial Virus and the Severity of Disease in Hospitalized Elderly in Vietnam


Sponsor

Tam Anh Research Institute

Enrollment

1,000 participants

Start Date

Oct 6, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This observational, prospective, multicenter study aims to estimate the proportion of RSV infection in adults aged 60 years and older hospitalized due to acute respiratory infections or exacerbation of cardiopulmonary disease.


Eligibility

Min Age: 60 Years

Inclusion Criteria6

  • Individuals ≥ 60 years old at the time of screening (calculated from the date of birth to the date of screening)
  • ARI or exacerbation of cardiopulmonary diseases diagnosed at the time of admission. ARI or ARI-compatible symptoms were defined as either:
  • New onset or increase from baseline of: nasal congestion, rhinorrhea, sore throat, hoarseness, cough, sputum production, dyspnea, wheezing, hypoxemia, or
  • Admitting diagnosis suggestive of ARI (e.g., pneumonia, upper respiratory infection, bronchitis, influenza, cough, viral respiratory illness, respiratory distress, or respiratory failure), or
  • Admitting diagnosis was the exacerbation of an underlying cardiac or pulmonary disease involving acute respiratory symptoms within the previous 2 weeks (e.g., congestive heart failure \[CHF\], chronic obstructive pulmonary disease \[COPD\], or asthma exacerbation).
  • The participant agrees to voluntarily participate in this study.

Exclusion Criteria4

  • Symptom onset \> 6 days prior to screening date
  • Acute symptoms confirmed to be unrelated to infection or as assessed by the investigator
  • Admission to any hospital within the 30 days preceding the screening date
  • Previously enrolled in the study in the last 45 days

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Tam Anh TP. Ho Chi Minh General Hospital

Ho Chi Minh City, Southern Vietnam, Vietnam

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07239583


Related Trials